DT Results in 3 weeks time15 Feb 2023 08:35
Interested to get PI's thoughts on what we are looking at for results in 3 weeks time.
RNS 11th Jan - For FY 2023, Darktrace now expects a year-over-year increase in its constant currency ARR of between 29.0% and 31.5% (previously 31% to 34%). This implies a year-over-year change in net ARR added of between (2)% and 6%.
Foreign exchange headwinds present early in the financial year have largely reversed, allowing us to moderate our reduction in revenue expectations. Based on this partial offset to lower ARR growth expectations for FY 2023, Darktrace is now expecting year-over-year revenue growth of between 29.5% and 31.0% (previously 30% to 33%).
These new guidance ranges imply that for FY 2023, Darktrace now expects that 47% to 51% of net ARR added, and 47% to 48% of revenue, will have been contributed in the first half of the financial year.
Based on strong preliminary 1H results, its plans for 2H operations and investment, and its expectation that it will be able to maintain operating efficiencies, Darktrace is increasing its expectations for the FY 2023 adjusted EBITDA margin to between 16.0% and 18.5% (previously 15% to 18%).
RNS 9TH Feb - A major provider of critical infrastructure services which has signed a multi-million-dollar, multi-year deal with Darktrace in Q2 of fiscal year 2023 - the single largest deal signed by the business to date
· A leading power transmission company with a majority stake in its National Power Grid
· An energy supplier with over 500 gas stations
· A not-for-profit electric power supplier with over 150,000 member-owned accounts
· A global chemicals company operating across 20+ countries
· A major provider of crude oil and natural gas listed on the NYSE
RNS 11th Jan - HEAL delivered to early adopters on schedule
As previously indicated, the fourth product in our Cyber AI Loop, HEAL, was delivered to early adopters before the end of CY 2022. This AI product is now installed in these real-world customer environments, enabling us to gain valuable feedback over the coming months as we continue to evolve our HEAL product family. HEAL will complete our vision of delivering a Cyber AI Loop, the first-ever solution that starts with assessing cyber risk, provides real-time cyber defense and, with HEAL, will extend our capabilities into cyber resilience.
PREVENT Momentum
RNS 11TH Jan - As previously indicated, we expect to be able to start assessing the performance of our PREVENT products in the second half of this financial year. While still early in the product introduction cycle, December PREVENT activity continued to make us optimistic about this product family's potential for near-term contributions to our business.
RNS 9TH Feb - Critical infrastructure is a top target for the world's most sophisticated and well-resourced cyber-attackers. Now with our PREVENT/OT product, defenders can prioritize and test the routes adversaries might take to get to the 'crown jewels'.